Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab.
接受利妥昔單抗治療的腎小球疾病患者使用提薪格呋單抗/西格格單抗(Evusheld)作為預防性暴露的安全性和有效性。
Clin Kidney J 2023-09-05
Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
2019年早產嬰兒和幼兒中呼吸道合胞病毒引起的急性下呼吸道感染的全球疾病負擔和風險因素:對聚合和個別參與者數據的系統性回顧和荟萃分析。
Lancet 2024-04-01
Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children.
呼吸道合胞病毒疫苗接種與免疫預防:實現保護幼兒的潛力。
Lancet 2024-09-12